A carregar...
Long-term management of type 2 diabetes with glucagon-like peptide-1 receptor agonists
Continuously reducing excess blood glucose is a primary goal for the management of type 2 diabetes (T2D). Most patients with T2D require glucose-lowering medications to achieve and maintain adequate glycemic control; however, treatment failure may occur, limiting treatment options. Glucagon-like pep...
Na minha lista:
| Publicado no: | Diabetes Metab Syndr Obes |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove Medical Press
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5357070/ https://ncbi.nlm.nih.gov/pubmed/28331351 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DMSO.S126763 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|